Mild Behavioral Impairment

Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1551.

Cherrier MM, Mendez MF, Perryman KM, Pachana NA, Miller BL, Cummings JL. Frontotemporal Dementia Versus Vascular Dementia: Differential Features on Mental Status Examination. J Am Geriatr Soc 1997;45:579-583.

McKeith IG, Dickson DW, Lowe J et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-1872.

Stevens M, Swieten JC van, Duijn CM van, Tibben A, Niermeijer MF. Familiare vormen van frontotemporale dementie. Ned Tijdschr Geneesk 1995;139:871-875.

Brun A, Englund B, Gustafson L, et al for the Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatr 1994;57:416-418.

Rosso SM, Swieten JC van. Frontotemporale Dementie. Ned Tijdschr Neurol 2000;1:5-11.

Knopman DS, Boeve BF, Parisi JE et al. Antemortum Diagnosis of Frontotemporal Lobar Degeneration.Ann Neurol 2005;57:480-488.

Snowden JS, Neary D, Mann D. Fronto-temporal lobar degeneration: frontotemporal dementia, progressive aphasia, semantic dementia. Clin Neurol Neurosurg Monographs. Churchill Livingstone. 1996.

Petersen RC, Doody R, Kurz A, et al. Current Concepts in Mild Cognitive Impairment.Arch Neurol 2001;58:1985-1993.

Taragano FE,Allegri RF. Mild Behavioral Impairment:The Early Diagnosis. Eleventh Congress of the International Psychogeriatric Association. Chicago, Illinois, USA. 2003,17-22 August. Abstract S002-002,12.

Mendonça A de, Ribeiro F, Guerreiro M, Garcia C. Frontotemporal mild cognitive impairment. J Alzh Dis 2004;6:1-9

Kertesz A, Davidson W, Fox H. Frontal behavioural inventory. Diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 1997;24:29-36.

Starkstein SE,Mayberg HS, Preziosi TJ,Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992;4:134-139.

Starkstein SE, Petracca G, Chemerinski E, Kremer J. Syndromic validity of apathy in AD.Am J Psychiatry 2001;158:872-877.

Almkvist O. Cognitive Syndrome(s) in preclinical and Clinical Vascular Dementia. Internat Psychogeriatr 2003;15:127-131.

Geda YE, Smith GE, Knopman DS, et al. De novo genesis of neuropsychiatric symptoms in Mild Cognitive Impairment (MCI). Internat Psychogeriatr 2004;6:51-60.

Sparks DL, Markesbery WR.Altered serotonergic and cholinergic synaptic markers in Pick’s disease.Arch Neurol 1991;48:796-799.

Swartz JR, Miller BL, Lesser IM, Darby AL. Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry. 1997;58:212-216.

Kremer J.The Fronto-Temporal Dementia Puzzle: A Diagnostic and Therapeutic Challenge. Eleventh Congress of the International Psychogeriatric Association. Chicago, Illinois, USA. 2003, 17-22 August.Abstract S002-004,13.

Anderson C, Östberg P,Wahlund L-O.Treatment strategies in frontotemporal lobar degeneration. Neurobiology of aging 2004;25:S188.

Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G, Bava A. Rivastigmine in Frontotemporal Dementia.An Open-Label Study. Drugs Aging 2004;21:931-937.

Bowler J. Epidemiology: Identifying Vascular Cognitive Impairment. Internat Psychogeriatr 2003;15:115-122.

Petersen RC, Smith GE,Waring SC, et al. Mild Cognitive Impairment: Clinical characterization and outcome.Archives Neurology 1999;56:303-308.

Gauthier S, Rockwood K. Does vascular MCI Progress at a Different Rate Than Does Amnestic MCI? Internat Psychogeriatr 2003;15:257-259.